Pityriasis rosea - Evidence for and against and infectious aetiology

Epidemiology and Infection

Volumn 132, Issue 3, 2004, Pages 381-390

  Chuh, A ^a,c   Chan, H ^a   Zawar, V ^b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b NDMVPS Medical College and Research Centre   (India)

^c Bonham Surgery   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; ERYTHROMYCIN; MINOCYCLINE; PLACEBO;

ANAMNESIS; ANTIMICROBIAL ACTIVITY; ATOPY; AUTOIMMUNITY; BLOOD CULTURE; CHLAMYDIA; CYTOMEGALOVIRUS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE EXACERBATION; DRUG MECHANISM; ECONOMIC ASPECT; EPSTEIN BARR VIRUS; EVIDENCE BASED MEDICINE; FEMALE; GENETIC PREDISPOSITION; HUMAN; HUMAN HERPESVIRUS 6; HUMAN HERPESVIRUS 7; HYPOTHESIS; IMMUNOMODULATION; INFLUENZA VIRUS; LEGIONELLA; MALE; MYCOPLASMA; PARAINFLUENZA VIRUS; PARVOVIRUS; PICORNAVIRUS; PITYRIASIS ROSEA; RASH; RECURRENT DISEASE; RESPIRATORY TRACT INFECTION; REVIEW; SEASONAL VARIATION; SOCIAL ASPECT; ULTRAVIOLET RADIATION; VIROGENESIS;

BACTERIAL INFECTIONS; DISEASE PROGRESSION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; PITYRIASIS ROSEA; PROGNOSIS; RISK FACTORS; SEASONS; VIRUS DISEASES;

EID: 2642558756     PISSN: 09502688     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0950268804002304     Document Type: Review

References (82)

1. Percival GH. Pityriasis rosea. Br J Dermatol 1932; 44: 241-253.
2. Björnberg A, Hellgren L. Pityriasis rosea. A statistical, clinical and laboratory investigation of 826 patients and matched healthy controls. Acta Derm Venereol 1962; 42: 50.
3. Chuang TY, Ilstrup DM, Perry HO, Kurland LT. Pityriasis rosea in Rochester, Minnesota, 1969 to 1978. J Am Acad Dermatol 1982; 7: 80-89.
4. Wile UJ. Experimental transmission of pityriasis rosea. A preliminary report. Arch Dermatol Syph 1927; 16: 185-188.
5. Salin RW, Curtis AC, Wheeler A. Treatment of pityriasis rosea with convalescent plasma, gamma globulin and pooled plasma. Arch Dermatol 1957; 76: 659-662.
6. Niles HD, Klumpp HH. Pityriasis rosea: review of the literature and report of two hundred and nineteen cases, in thirty-eight of which convalescent serum was used. Arch Dermatol Syph 1940; 41: 265-294.
7. Aoshima T, Komura J, Ofuji S. Virus-like particles in the herald patch of pityriasis rosea. Dermatologica 1981; 162: 64-65.
8. El-Shiemy S, Nassar A, Mokhtar M, Mabrouk D. Light and electron microscopic studies of pityriasis rosea. Int J Dermatol 1987; 26: 237-239.
9. Davis GB, Kyle MG. Pityriasis rosea in pigs. NZ Vet J 1969; 17: 71.
10. Aiello SE, Mays A. The Merck veterinary manual, 8th edn. Whitehouse, New Jersey, USA, 2002. Available at: http://www.merckvetmanual.com/mvm/index.jsp.
11. Hannan MA, Rahman MM, Haque A, Ahmed HU. Stroke: seasonal variation and association with hypertension. Bangladesh Med Res Counc Bull 2001; 27: 69-78.
12. Cohen EL. Pityriasis rosea. Br J Dermatol 1967; 79: 533-537.
13. Messenger AG, Knox EG, Summerly R, et al. Case clustering in pityriasis rosea: support for role of an infective agent. Br Med J (Clin Res Ed) 1982; 284: 371-373.
14. Ahmed MA. Pityriasis rosea in the Sudan. Int J Dermatol 1986; 25: 184-185.
15. Olumide Y. Pityriasis rosea in Lagos. Int J Dermatol 1987; 26: 234-236.
16. de Souza Sittart JA, Tayah M, Soares Z. Incidence pityriasis rosea of Gibert in the Dermatology Service of the Hospital do Servidor Publico in the state of Sao Paulo. Med Cutan Ibero Lat Am 1984; 12: 336-338.
17. Cheong WK, Wong KS. An epidemiological study of pityriasis rosea in Middle Road Hospital. Singapore Med J 1989; 30: 60-62.
18. Vollum DI. Pityriasis rosea in the African. Trans St Johns Hosp Dermatol Soc 1973; 59: 269-271.
19. Jacyk WK. Pityriasis rosea in Nigerians. Int J Dermatol 1980; 19: 397-399.
20. Harman M, Aytekin S, Akdeniz S, Inaloz HS. An epidemiological study of pityriasis rosea in the Eastern Anatolia. Eur J Epidemiol 1998; 14: 495-497.
21. Tay YK, Goh CL. One-year review of pityriasis rosea at the National Skin Centre, Singapore. Ann Acad Med Singapore 1999; 28: 829-831.
22. Miller TH. Pityriasis rosea: report of three cases in one family with clinical variations in two of them. Arch Dermatol Syph 1941; 44: 66-68.
23. White W. Pityriasis rosea in sisters. Br Med J 1973; 2: 245.
24. Bose F. Is pityriasis rosea infectious? Lancet 1981; 1: 662.
25. Davies SWV. Case clustering in pityriasis rosea: support for role of an infective agent [Correspondence]. Br Med J (Clin Res Ed) 1982; 284: 1478.
26. Bolt GL. Case clustering in pityriasis rosea: support for role of an infective agent [Correspondence]. Br Med J 1982; 284: 977.
27. Halkier-Sorensen L. Recurrent pityriasis rosea. New episodes every year for five years. A case report. Acta Derm Venereol 1990; 70: 179-180.
28. Abercrombie GF. Pityriasis rosea 1964-65. J R Coll Gen Pract 1968; 16: 268-274.
29. Chuang TY, Perry HO, Ilstrup, DM, Kurland LT. Recent upper respiratory tract infection and pityriasis rosea: a case-control study of 249 matched pairs. Br J Dermatol 1983; 108: 587-591.
30. Traore A, Korsaga-Some N, Niamba P, et al. Pityriasis rosea in secondary schools in Ouagadougou, Burkina Faso. Ann Dermatol Venereol 2001; 128: 605-609.
31. McPherson A, McPherson K, Ryan T. Is pityriasis rosea an infectious disease? Lancet 1980; 2: 1077.
32. Pariser RJ, Pariser DM. Primary care physicians' errors in handling cutaneous disorders. J Am Acad Dermatol 1987; 17: 239-245.
33. Alexander FE, Boyle P, Carli PM, et al. Spatial temporal patterns in childhood leukaemia: further evidence for an infectious origin. EUROCLUS project. Br J Cancer 1998; 77: 812-817.
34. Nakamura Y, Yanagawa I, Kawasaki T. Temporal and geographical clustering of Kawasaki disease in Japan. Prog Clin Biol Res 1987; 250: 19-32.
35. Cameron D, Jones IG. Case clustering in pityriasis rosea: support for role of an infective agent [Correspondence]. Br Med J (Clin Res Ed) 1982; 284: 1478.
36. Chuh AAT, Lee A, Molinari N. Case clustering in pityriasis rosea - a multi-centre epidemiology study in primary care settings in Hong Kong. Arch Dermatol 2003; 139: 489-493.
37. Drago F, Ranieri E, Malaguti F, et al. Human herpesvirus 7 in pityriasis rosea. Lancet 1997; 349: 1367-1368.
38. Drago F, Ranieri F, Malaguti F, Battifoglio ML. Human herpesvirus 7 in patients with pityriasis rosea. Electron microscopy investigations and polymerase chain reaction in mononuclear cells, plasma and skin. Dermatology 1997; 195: 374-378.
39. Drago F, Malaguti F, Ranieri E, et al. Human herpes virus-like particles in pityriasis rosea lesions: an electron microscopy study. J Cutan Pathol 2002; 29: 359-361.
40. Watanabe T, Sugaya M, Nakamura K, Tamaki K. Human herpesvirus 7 and pityriasis rosea [Correspondence]. J Invest Dermatol 1999; 113: 288-289.
41. Watanabe T, Kawamura T, Jacob SE, et al. Pityriasis rosea is associated with systemic active infection with both human herpesvirus-7 and human herpesvirus-6. J Invest Dermatol 2002; 119: 793-797.
42. Vag T, Sonkoly E, Kemeny B, et al. Pityriasis rosea [in Hungarian]. Orv Hetil 2003; 144: 1623-4629.
43. Kempf W, Adams V, Kleinhans M, et al. Pityriasis rosea is not associated with human herpesvirus 7. Arch Dermatol 1999; 135: 1070-1072.
44. Yoshida M. Detection of human herpesvirus 7 in patients with pityriasis rosea and healthy individuals [Correspondence]. Dermatology 1999; 199: 197.
45. Yasukawa M, Sada E, Machino H, Fugita S. Reactivation of human herpesvirus 6 in pityriasis rosea. Br J Dermatol 1999; 140: 169-170.
46. Kosuge H, Tanaka-Taya K, Miyoshi H, et al. Epidemiological study of human herpesvirus-6 and human herpesvirus-7 in pityriasis rosea. Br J Dermatol 2000; 143: 795-798.
47. Offidani A, Pritelli E, Simonetti O, et al. Pityriasis rosea associated with herpesvirus 7 DNA [Correspondence]. J Eur Acad Dermatol Venereol 2000; 14: 313-314.
48. Wong WR, Tsai CY, Shih SR, Chan HL. Association of pityriasis rosea with human herpesvirus-6 and human herpesvirus-7 in Taipei. J Formos Med Assoc 2001; 100: 478-483.
49. Karabulut AA, Kocak M, Yilmaz N, Eksioglu M. Detection of human herpesvirus 7 in pityriasis rosea by nested PCR. Int J Dermatol 2002; 41: 563-567.
50. Chuh AAT, Chiu SSS, Peiris JSM. Human herpesvirus 6 and 7 DNA in peripheral blood leukocytes and plasma in patients with pityriasis rosea by polymerase chain reaction - a prospective case control study. Acta Derm Venereol 2001; 81: 289-290.
51. Chuh AAT. The association of pityriasis rosea with cytomegalovirus, Epstein-Barr virus and parvovirus B19 infections - a prospective case control study by polymerase chain reaction and serology. Eur J Dermatol 2003; 13: 25-28.
52. Bonafé JL, Icart J, Perpere M, et al. Histopathologic, ultrastructural, immunologic and virologic study of Gibert's pityriasis rosea. Ann Dermatol Venereol 1982; 109: 855-861.
53. Marcus-Farber BS, Bergman R, Ben Porath E, et al. Serum antibodies to parvovirus B19 in patients with pityriasis rosea. Dermatology 1997; 194: 371.
54. Raskin J. Possible dermatropic virus associated with pityriasis rosea. Preliminary study. Acta Derm Venereol 1968; 48: 474-481.
55. Metz J. An electron microscopic investigation of the pityriasis rosea. J Cutan Pathol 1977; 4: 228.
56. Neubert U, Ring J. Immunological monitoring in pityriasis rosea. 17th International Congress of Dermatology, Berlin, 1987: 464.
57. Aractingi S, Morinet F, Mokni M, et al. Absence of picornavirus genome in pityriasis rosea. Arch Dermatol Res 1996; 289: 60-61.
58. Hudson LD, Adelman S, Lewis CW. Pityriasis rosea. Viral complement fixation studies. J Am Acad Dermatol 1981 ; 4: 544-546.
59. Gjenero-Margan I, Vidovic R, Drazenovic V. Pityriasis rosea Gibert: detection of Legionella micdadei antibodies in patients. Eur J Epidermiol 1995; 11: 459-462.
60. Chuh AAT, Chan HHL. Prospective case-control study of chlamydia, legionella and mycoplasma infections in patients with pityriasis rosea. Eur J Dermatol 2002; 12: 170-173.
61. Ishibashi A, Ueda I, Fujita K. Pityriasis rosea Gibert and Mycoplasma pneumoniae infection. J Dermatol 1985; 12: 97-100.
62. Sharma PK, Yadav TP, Gautam RK, et al. Erythromycin in pityriasis rosea: a double-blind, placebo-controlled clinical trial. J Am Acad Dermatol 2000; 42: 241-244.
63. Markham FS. A search for filtrable viruses in cutaneous diseases of unknown etiology. Arch Derm Syph 1940; 41: 261.
64. Felsher Z. Virus studies on cutaneous material, inoculation of chick chorioallantoic membrane with material from cutaneous lesions. J Invest Dermatol 1947; 8: 123-124.
65. Wright AD, Francis RD. Pityriasis rosea - an etiology study. Arch Dermatol 1961; 84: 87-89.
66. Kempf W, Burg G. Pityriasis rosea - a virus-induced skin disease? An update. Arch Virol 2000; 145: 1509-1520.
67. Garcia e Silva L, Gardner PS. Pityriasis rosea - a virological study. Br J Dermatol 1968; 80: 514-515.
68. Morgan-Capner P, Hodgson J, Pattison J, et al. Case clustering in pityriasis rosea: support for role of an infective agent [Correspondence]. Br Med J 1982; 284: 977.
69. Hazen HH. The etiology and treatment of pityriasis rosea. J Am Med Assoc 1928; 91: 645.
70. Arndt KA, Paul BS, Stern RS, Parrish JA. Treatment of pityriasis rosea with UV radiation. Arch Dermatol 1983; 119: 381-382.
71. Leenutaphong V, Jiamton S. UVB phototherapy for pityriasis rosea: a bilateral comparison study. J Am Acad Dermatol 1995; 33: 996-999.
72. Leonforte JF. Pityriasis rosea: exacerbation with corticosteroid treatment. Dermatologica 1981 ; 163: 480-481.
73. Robinson Jr HM, Zeligman I, Robinson RCV, et al. Erythromycin in treatment of dermatoses. Report on 1695 patients. Arch Derm Syph (Chic) 1954; 70: 325.
74. Labro MT. Anti-inflammatory activity of macrolides: a new therapeutic potential? J Antimicrob Chemother 1998; 41 (Suppl B): 37-46.
75. Loo WJ, Kirtschig G, Wojnarowska F. Minocycline as a therapeutic option in bullous pemphigoid. Clin Exp Dermatol 2001; 26: 376-379.
76. Burch PRJ, Rowell NR. Pityriasis rosea - an autoaggressive disease? Br J Dermatol 1970; 82: 549-560.
77. Hosokawa H, Horio S, Takiuchi Y, et al. Naturally occurring T lymphocytotoxic antibody in viral and related skin diseases. Acta Derm Venereol 1984; 64: 275-280.
78. Durusoy C, Alpsoy E, Yilmaz E. Pityriasis rosea in a patient with Behcet's disease treated with interferon alpha 2A. J Dermatol 1999; 26: 225-228.
79. Chuh AAT. A prospective case control study of autoimmune markers in patients with pityriasis rosea. Clin Exp Dermatol 2003; 28: 449-450.
80. Hendricks AA, Lohr JA. Pityriasis rosea in infancy. Arch Dermatol 1979; 115: 896-897.
81. Hyatt H. Pityriasis rosea in a three month old. Arch Pediatr 1960; 77: 364.
82. Truhan AP. Pityriasis rosea. Am Fam Physician 1984; 29: 193-196.